These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3341058)
1. Infection with hepatitis delta and human immunodeficiency viruses among hemophiliacs in Japan. Inagaki M; Miura T; Taki M; Saito N; Yamada K; Unuma T; Tsuda F; Miyakawa Y; Mayumi M Transfusion; 1988; 28(1):18-20. PubMed ID: 3341058 [TBL] [Abstract][Full Text] [Related]
2. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. Rizzetto M; Morello C; Mannucci PM; Gocke DJ; Spero JA; Lewis JH; Van Thiel DH; Scaroni C; Peyretti F J Infect Dis; 1982 Jan; 145(1):18-22. PubMed ID: 7033398 [TBL] [Abstract][Full Text] [Related]
3. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study. Rosina F; Saracco G; Rizzetto M N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749 [TBL] [Abstract][Full Text] [Related]
4. [Delta agent in hemophiliacs in Japan--with special reference to hepatitis B virus and HTLV-III/LAV]. Miura T; Inagaki M; Taki M; Tomita Y; Saito N; Yamada K; Ise I; Tsuda F Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1427-31. PubMed ID: 3825459 [No Abstract] [Full Text] [Related]
5. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Ghany MG; Leissinger C; Lagier R; Sanchez-Pescador R; Lok AS Dig Dis Sci; 1996 Jun; 41(6):1265-72. PubMed ID: 8654162 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan. Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. Amini S; Mahmoodi MF; Andalibi S; Solati AA J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis delta infection among multiply-transfused hemophiliacs. Lemon SM; Becherer PR; Wang JG; White GC; Lesesne H; Janco RL; Hanna WT; Davis C; Johnson CA; Poon MC Prog Clin Biol Res; 1991; 364():351-60. PubMed ID: 2020710 [No Abstract] [Full Text] [Related]
9. [Delta agent infection in hemophilia]. Miura T; Inagaki M Rinsho Byori; 1987 Sep; Spec No 73():74-8. PubMed ID: 3437535 [No Abstract] [Full Text] [Related]
10. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Eyster ME; Sanders JC; Battegay M; Di Bisceglie AM Dig Dis Sci; 1995 Jul; 40(7):1583-8. PubMed ID: 7628288 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C infection in children with hemophilia A and B. Blanchette VS; Vorstman E; Shore A; Wang E; Petric M; Jett BW; Alter HJ Blood; 1991 Jul; 78(2):285-9. PubMed ID: 1712646 [TBL] [Abstract][Full Text] [Related]
12. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden. Schulman S; Wiechel B Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Rizzetto M; Purcell RH; Gerin JL Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036 [TBL] [Abstract][Full Text] [Related]
15. [Study of serological and biological markers in viral hepatitis. 157 hemophiliacs]. Parquet-Gernez A; Boulanger-Fasquelle P; Maniez-Montreuil M; Goudemand M Rev Fr Transfus Immunohematol; 1981 Nov; 24(5):463-82. PubMed ID: 6798669 [TBL] [Abstract][Full Text] [Related]
16. Delta hepatitis in Malaysia. Sinniah M; Dimitrakakis M; Tan DS Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of hepatitis-B antigen (HB S Ag) and its antibody (Anti-HB S) among London hemophiliacs and blood donors from London and two tropical areas. Islam MN; Banatvala JE Transfusion; 1976; 16(3):237-41. PubMed ID: 936273 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038 [TBL] [Abstract][Full Text] [Related]
19. Concurrent hepatitis B, delta and human immunodeficiency virus infection in hemophiliacs. Hatzakis A; Hadziyannis S; Maclure M; Louizou C; Yannitsiotis A; Mandalaki T Thromb Haemost; 1987 Aug; 58(2):791. PubMed ID: 3672432 [No Abstract] [Full Text] [Related]
20. Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to human immunodeficiency virus. Jin ZW; Cleveland RP; Kaufman DB J Allergy Clin Immunol; 1989 Jan; 83(1):165-70. PubMed ID: 2913135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]